Regenerative Medical Technology Group Inc. (RMTG)
↓ Download CSV- Sector Retail Trade
- Fiscal year ends Dec 31
In fiscal 2025, Regenerative Medical Technology Group Inc. reported revenue of $5.10M, up 24.2% from the prior year. The company ran a net loss, with a net margin of -153.2% and a gross margin of 55.1%. It held $4.49M in total assets against $39.23M in total liabilities.
Key ratios (FY2025)
55.1%
Gross margin
-17.0%
Operating margin
-153.2%
Net margin
+24.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.10M | $4.11M | $2.41M | $1.53M | $437.9K | $55.1K | $30.1K | $50.1K | $29.2K | — |
| Cost of Revenue | $2.29M | $1.28M | $734.3K | $653.3K | $287.8K | $44.0K | $55.5K | $68.3K | $4.8K | — |
| Gross Profit | $2.81M | $2.82M | $1.68M | $877.0K | $150.1K | $11.1K | -$25.4K | -$18.2K | $24.4K | — |
| Operating Income | -$867.2K | $81.2K | -$715.2K | — | — | — | — | — | — | — |
| Net Income | -$7.81M | -$5.56M | -$9.81M | -$5.51M | -$12.88M | -$5.90M | -$2.51M | -$2.06M | -$377.0K | — |
| EPS (Diluted) | $-0.62 | $-0.44 | $-0.79 | $-0.45 | $-1.12 | $-0.63 | $-0.47 | $-0.50 | — | — |
| Total Assets | $4.49M | $3.82M | $2.88M | $8.08M | $9.31M | $219.7K | $26.4K | $34.6K | $7.9K | — |
| Total Liabilities | $39.23M | $31.18M | $24.67M | $20.06M | $16.06M | $6.55M | $7.30M | $4.57M | $2.57M | — |
| Shareholders' Equity | -$34.75M | -$27.36M | -$21.80M | -$11.98M | -$6.76M | -$6.41M | -$7.36M | -$4.54M | -$2.56M | -$5.51M |
| Cash & Equivalents | $956.7K | $1.17M | $530.5K | $1.65M | $2.98M | $42.5K | $23.4K | $30.8K | $7.8K | $6.6K |
| Operating Cash Flow | -$706.5K | $850.7K | -$419.2K | -$1.11M | -$9.88M | -$322.7K | -$362.3K | -$244.6K | -$6.1K | — |
| Capital Expenditures | $602.6K | $215.4K | $385.6K | $198.4K | — | — | — | $4.0K | — | — |
| Shares Outstanding | 13.14M | 12.54M | 12.49M | 12.44M | 12.09M | 10.87M | 7.96M | 4.90M | 3.74M | — |